Latham BioPharm Group

Exhibitor

Latham Biopharm Group (LBG), a part of Sia Partners, is a recognized leader in the vaccine and life sciences consulting sector. Our expertise lies in moving projects effectively and efficiently through all stages—from early research at the bench, through development, scale-up, and technology transfer, to full commercialization.

We specialize in solving complex challenges across product development, preclinical, regulatory affairs, quality operations, and clinical development. Additionally, our deep knowledge in U.S. Government and NGO funding allows us to secure and manage vital non-dilutive funding for our clients, empowering their innovations.

Since joining Sia Partners in 2022, LBG has expanded its global reach and continues to serve clients in pharmaceuticals, biotechnology, CROs, academia, and the medical device/diagnostic industries with tailored consulting solutions.

Core Services

1. Product Development
   • Comprehensive support from early research through product launch and beyond
   • Expertise in development, scale-up, and technology transfer for vaccine and pharmaceutical products
2. Non-Dilutive Funding
   • Identification, pursuit, and management of project funding from U.S. Government agencies and NGOs
   • Expertise in managing U.S. Government-funded programs to advance client technologies
3. Strategic Consulting
   • Business intelligence and market analysis to support decision-making
   • Guidance on regulatory, product development, and business strategies

LBG serves a diverse range of clients, including:

• Pharmaceutical and biotech companies
• Contract Research Organizations (CROs)
• Academic institutions
• Medical device and diagnostic companies

Locations and Contact Information

• Headquarters: 6810 Deerpath Road, Suite 405
  Elkridge, Maryland 21075-6214
• Phone: 978.266.9151
• Email: info@lathambiopharm.com
• Website: https://www.lathambiopharm.com/
• Social Media: https://www.linkedin.com/company/latham-biopharm-group/

website